Abstract/Details

The study of retinoic acids and <i>Rhodiola</i> as potential chemopreventional and chemotherapeutic reagents of breast cancer


2008 2008

Other formats: Order a copy

Abstract (summary)

According to the National Cancer Institute, breast cancer is second only to lung cancer in cancer-related deaths for women in the United States (American Cancer Society). Despite a gradual decline in deaths due to breast cancer (likely attributable to increased screening), there is a rise in the incidence of newly-diagnosed breast cancer. Thus protective therapies for breast cancer are a new arena which will become of increasing importance. The work presented in this dissertation demonstrated the possible treatments which might be effective in the fight against breast cancer and the pathways involved in the prevention and therapy.

An early full-term pregnancy imparts a significant protection for women from getting breast cancer. In animals, this protection can be mimicked by a short-term exposure to physiological doses of ovarian hormones. In my dissertation, I investigated the ability of retinoids, such as 9-cis retinoic acid, all-trans retinoic acid, and N-4-hydroxyphenylretinamide (4-HPR), to sensitize the ductal epithelial cells of virgin mammary glands to DNA damage responses using a whole-organ culture system. My data suggest that sensitization of the mammary epithelium to p53-dependent apoptosis is a common pathway, which is engaged by retinoids as well as ovarian hormones.

I went on to investigate the effect and mechanism of another possible chemopreventive and chemotherapeutic agent, Rhodiola Crenulata. Rhodiola is a perennial plant which grows in the high Tundra regions of Tibet and Siberia. Though it has been used for a long time in the eastern traditional medicine, Rhodiola has never been used in the treatment of breast cancer. In this dissertation, I showed that dietary Rhodiola is effective in increasing the survival time of mice bearing tumor grafts. In vitro analysis shows that Rhodiola is capable of reducing proliferation and increasing death of certain breast cancer cells. Rhodiola is demonstrated to inhibit the motility and invasion of breast cancer cells. Caspase-dependent and-independent pathways as well as Akt and p53 pathways were shown to be involved in the chemoprevention and chemotherapeutic action of Rhodiola on breast cancer.

Indexing (details)


Subject
Molecular biology
Classification
0307: Molecular biology
Identifier / keyword
Biological sciences; Breast cancer; Chemoprevention; Retinoic acids; Rhodiola
Title
The study of retinoic acids and <i>Rhodiola</i> as potential chemopreventional and chemotherapeutic reagents of breast cancer
Author
Tu, Yifan
Number of pages
172
Publication year
2008
Degree date
2008
School code
0118
Source
DAI-B 69/08, Dissertation Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
ISBN
9780549663621
Advisor
Schneider, Sallie
Committee member
Arenus, Richard; Osborne, Barbara; Shetty, Kalidas
University/institution
University of Massachusetts Amherst
Department
Molecular & Cellular Biology
University location
United States -- Massachusetts
Degree
Ph.D.
Source type
Dissertations & Theses
Language
English
Document type
Dissertation/Thesis
Dissertation/thesis number
3315484
ProQuest document ID
219908098
Copyright
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
http://search.proquest.com/docview/219908098
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.